KRM Ayurveda IPO
UpcomingAlready have an account? Apply now
KRM Ayurveda IPO details
Schedule of KRM Ayurveda
| Issue open date | 21 Jan 2026 |
| Issue close date | 23 Jan 2026 |
| UPI mandate deadline | 23 Jan 2026 (5 PM) |
| Allotment finalization | 27 Jan 2026 |
| Refund initiation | 28 Jan 2026 |
| Share credit | 28 Jan 2026 |
| Listing date | 29 Jan 2026 |
| Mandate end date | 07 Feb 2026 |
| Lock-in end date for anchor investors (50%) | 23 Feb 2026 |
| Lock-in end date for anchor investors (remaining) | 24 Apr 2026 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About KRM Ayurveda
KRM Ayurveda Limited was incorporated in September 2019 and converted into a public limited company in December 2024. The company is promoted by Mr Puneet Dhawan and Mrs Tanya Dhawan. It operates in the AYUSH healthcare segment, with a focus on integrating classical Ayurvedic knowledge with modern clinical practices. The company runs a network of hospitals and clinics across multiple cities in India and also offers telemedicine services, enabling domestic and international patient outreach. It initially commenced operations as a speciality kidney care provider and has since expanded its treatment portfolio to cover chronic and lifestyle-related conditions such as liver disorders, diabetes, fatty liver, arthritis, and preventive healthcare.KRM Ayurveda follows a patient-centric business model that combines in-person consultations, hospital-based care, and tele-consultation services. Revenues are generated through healthcare services, wellness programs, and associated treatment offerings. Its key strengths include specialised Ayurvedic expertise, an expanding physical and digital presence, personalised treatment protocols, and a growing brand in holistic healthcare.
Financials of KRM Ayurveda
Issue size
| Funds Raised in the IPO | Amount |
| Total issue size | 77.49 |
| Fresh Issue – Proceeds go to the company | 77.49 |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Capital Expenditure for Telemedicine Facilities | 13.67 (17.64%) |
| CRM Software & Hardware Infrastructure | 1.42 (1.83%) |
| Human Resources | 5.44 (7.02%) |
| Repayment / Prepayment of Loan | 12.5 (16.13%) |
| Working capital requirements | 18 (23.23%) |
| General corporate purposes | 26.46 (34.15%) |
Strengths
- Integrated Ayurvedic healthcare model combining hospitals, clinics, and telemedicine.
- Strong promoter experience with deep domain knowledge in Ayurveda.
- Specialised expertise in chronic and lifestyle disease management.
- Growing physical presence across multiple Indian states with global tele-reach.
- Increasing brand recognition in the D2C and holistic healthcare segment.
Risks
- High dependence on North India for a significant portion of revenues.
- Operations are asset-light, with most hospitals and clinics on leased premises.
- Business is working-capital intensive with a history of negative cash flows.
- High employee attrition could impact service quality and scalability.
- Dependence on brand reputation in a highly competitive and unregulated AYUSH market.